logo

Aveo Pharmaceuticals, Inc. (AVEO)



Trade AVEO now with
  Date
  Headline
11/12/2019 7:21:33 AM AVEO Oncology Q3 EPS $0.10 Vs Loss $0.18 Last Year
11/4/2019 7:25:31 AM AVEO Oncology Announces Regulatory Update For Tivozanib In Renal Cell Carcinoma
9/30/2019 7:06:12 AM AVEO Oncology Begins Enrollment In Phase 1b/2 Trial On FOTIVDA In Combination With IMFINZI
12/12/2018 7:11:03 AM AVEO Oncology Announces Immuno-Oncology Clinical Collaboration With AstraZeneca
11/9/2018 7:13:02 AM AVEO Oncology Q3 Net Loss $22.2 Mln Or $0.18/shr Vs. Net Loss $26.4 Mln Or $0.22/shr Last Year
10/22/2018 7:08:06 AM AVEO Oncology, EUSA Pharma Announce Updated Interim Results From Phase 2 Portion Of TiNivo Study
10/1/2018 7:14:49 AM AVEO Oncology Begins Topline Analysis Of Phase 3 TIVO-3 Trial
8/17/2018 9:11:47 AM AVEO Pharmace Prices Public Offering Of 2.50 Mln Shares At $2.26/shr
7/19/2018 6:34:42 AM AVEO Oncology Expects To Report Topline Results From TIVO-3 Study In Q4
  
 
>